Skip to main content
Veterinary Medicines

Dexafast 2 mg/ml solution for injection for horses, cattle, goats, pigs, dogs and cats

Authorised
  • Dexamethasone sodium phosphate

Product identification

Medicine name:
Dexafast 2 mg/ml solution for injection for horses, cattle, goats, pigs, dogs and cats
Dexafast 2 mg/ml injektionsvæske, opløsning
Active substance:
  • Dexamethasone sodium phosphate
Target species:
  • Horse
  • Cattle
  • Dog
  • Goat
  • Cat
  • Pig
Route of administration:
  • Intraarticular use
  • Intramuscular use
  • Intravenous use
  • Periarticular use
  • Subcutaneous use

Product details

Active substance and strength:
  • Dexamethasone sodium phosphate
    2.63
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Solution for injection
Withdrawal period by route of administration:
  • Intraarticular use
    • Horse
      • Meat and offal
        8
        day
  • Intramuscular use
    • Cattle
      • Meat and offal
        8
        day
      • Milk
        72
        hour
    • Dog
    • Goat
      • Meat and offal
        8
        day
      • Milk
        72
        hour
    • Horse
      • Meat and offal
        8
        day
    • Cat
    • Pig
      • Meat and offal
        2
        day
  • Intravenous use
    • Cattle
      • Meat and offal
        8
        day
      • Milk
        72
        hour
    • Dog
    • Goat
      • Meat and offal
        8
        day
      • Milk
        72
        hour
    • Horse
      • Meat and offal
        8
        day
    • Cat
    • Pig
      • Meat and offal
        6
        day
  • Periarticular use
    • Horse
      • Meat and offal
        8
        day
  • Subcutaneous use
    • Dog
    • Cat
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QH02AB02
Authorisation status:
  • Valid
Authorised in:
  • Denmark
Package description:
  • Clear glass (Type I Ph. Eur.) vial of 100 ml closed with a bromobutyl rubber stopper and sealed with an aluminium cap.Carton of 12 x 100 ml
  • Clear glass (Type I Ph. Eur.) vial of 100 ml closed with a bromobutyl rubber stopper and sealed with an aluminium cap.Carton of 6 x 100 ml
  • Clear glass (Type I Ph. Eur.) vial of 100 ml closed with a bromobutyl rubber stopper and sealed with an aluminium cap.Carton of 1 x 100 ml
  • Clear glass (Type I Ph. Eur.) vial of 50 ml closed with a bromobutyl rubber stopper and sealed with an aluminium cap.Carton of 12 x 50 ml
  • Clear glass (Type I Ph. Eur.) vial of 50 ml closed with a bromobutyl rubber stopper and sealed with an aluminium cap.Carton of ml, 6 x 50 ml
  • Clear glass (Type I Ph. Eur.) vial of 50 ml closed with a bromobutyl rubber stopper and sealed with an aluminium cap.Carton of 1 x 50 ml
  • Clear glass (Type I Ph. Eur.) vial of 20 ml closed with a bromobutyl rubber stopper and sealed with an aluminium cap.Carton of 12 x 20 ml
  • Clear glass (Type I Ph. Eur.) vial of 20 ml closed with a bromobutyl rubber stopper and sealed with an aluminium cap.Carton of 6 x 20 ml
  • Clear glass (Type I Ph. Eur.) vial of 20 ml closed with a bromobutyl rubber stopper and sealed with an aluminium cap.Carton of 1 x 20 ml

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Livisto Int'l S.L.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Industrial Veterinaria S.A.
  • Animedica GmbH
Responsible authority:
  • Danish Medicines Agency
Authorisation number:
  • 60463
Date of authorisation status change:
Reference member state:
  • Ireland
Procedure number:
  • IE/V/0390/001
Concerned member states:
  • Austria
  • Belgium
  • Bulgaria
  • Croatia
  • Cyprus
  • Czechia
  • Denmark
  • Estonia
  • Finland
  • France
  • Germany
  • Greece
  • Hungary
  • Italy
  • Latvia
  • Lithuania
  • Netherlands
  • Poland
  • Portugal
  • Romania
  • Slovakia
  • Slovenia
  • Spain
  • United Kingdom (Northern Ireland)

Documents

Summary of Product Characteristics

English (PDF)
Published on: 25/09/2024
Download
Danish (PDF)
Published on: 5/02/2024
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."